Paper Details 
Original Abstract of the Article :
Forty patients affected by severe Parkinson's disease (PD) were treated with tolcapone as an adjunctive therapy to L-DOPA, for 3-7 months, until this drug was discontinued because of side-effects (2 diarrhoea, one of them with orthostatic hypotension, 2 increments of liver enzymes) or because of man...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1159/000050749

データ提供:米国国立医学図書館(NLM)

Switching Medications for Parkinson's Disease: A Case for Individualized Care

Parkinson's disease (PD) is a neurodegenerative disorder that can significantly impact mobility and quality of life. This study examines the effectiveness of switching from tolcapone to entacapone in patients with severe PD. The researchers evaluated the impact of these medications on L-DOPA dosage, 'on' time, and 'off' time, seeking to find a safe and effective treatment approach for managing severe PD symptoms.

Finding the Right Fit: A Personalized Approach to PD Treatment

The study highlights the importance of individualized treatment approaches for PD, acknowledging that different patients may respond differently to various medications. While both tolcapone and entacapone showed improvements in 'on' time and reductions in 'off' time, some patients experienced side effects, necessitating medication switches. This reinforces the need for close monitoring and adjustments based on individual patient responses.

Living with Parkinson's Disease: A Collaborative Journey

Managing PD is a collaborative journey between patient and healthcare provider. It's crucial to have open communication about symptoms, medication effects, and any potential concerns. Remember, there is no one-size-fits-all solution for PD, and finding the right treatment plan involves a personalized approach tailored to your unique needs.

Dr. Camel's Conclusion

This study reinforces the importance of individualized treatment approaches for PD, acknowledging the diverse responses to medications. It emphasizes the need for ongoing monitoring, communication with your healthcare provider, and a willingness to adjust treatment plans as needed. Remember, managing PD is a journey, and finding the right path requires collaboration, patience, and a personalized approach.

Date :
  1. Date Completed 2001-09-06
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

11455177

DOI: Digital Object Identifier

10.1159/000050749

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.